๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Therapeutic targeting of the p53 tumor suppressor gene

โœ Scribed by Gary A Beaudry; Arthur H Bertelsen; Michael I Sherman


Book ID
108476251
Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
877 KB
Volume
7
Category
Article
ISSN
0958-1669

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Mutations of p53 tumor-suppressor gene i
โœ Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hong ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 50 KB ๐Ÿ‘ 3 views

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We ana

p53 tumor-suppressor gene: Clues to mole
โœ Xin W. Wang; Curtis C. Harris ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 207 KB ๐Ÿ‘ 3 views

The tumor-suppressor gene product p53 is clearly a component in several biochemical pathways, including transcription, DNA repair, genomic stability, cell-cycle control and apoptosis, that are central to human carcinogenesis. The p53 is functionally inactivated by mutational, viral, and cellular mec